Canine primary liver tumors treated with stereotactic body radiation therapy: A case series
Veterinary Radiology & Ultrasound · 2024
DOI: 10.1111/vru.13336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Radiology & Ultrasound, 2024. Verfasst von Qiao Ying Pauline Chan und 2 weiteren Autor:innen. Beteiligte Einrichtung: ONE Cancer Care for Pets, Artarmon, New South Wales, Australia. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Radiosurgery, Dog Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Stereotactic body radiation therapy (SBRT) is an increasingly used alternative treatment option for nonresectable hepatocellular carcinoma (HCC) in people. Comparatively, the publication of SBRT of dogs with HCC is limited. The objective of this retrospective, descriptive case series was to evaluate the clinical outcomes and toxicity data of SBRT in dogs with HCC and imaging‐documented primary liver tumors using volumetric‐modulated arc therapy delivery at two private institutions. Medical records of 14 dogs treated between 2018 and 2023 were reviewed. All dogs had macroscopic tumors, and 9 of 14 dogs had HCC diagnoses confirmed on cytology or histopathology. The median longest tumor diameter was 5.5 cm. The median percentage of planning target volume relative to liver volume was 27.1%. Most dogs were treated with three daily fractions of 7–7.5 Gy. All dogs completed their radiotherapy protocols. Three of nine HCC dogs experienced partial responses and clinical improvement. Five of nine HCC dogs had stable disease. Overall median survival time was 164 days for nine HCC dogs (range: 93–706 days). One late grade 5 liver and two late grade 3 kidney side effects were reported. One dog received repeated SBRT to the same HCC treatment field, and one dog had two courses of SBRT to bifocal HCC treatment fields, both with no more than grade 2 acute and chronic toxicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ONE Cancer Care for Pets, Artarmon, New South Wales, Australia.
ORCID-Profile: Qiao Ying Pauline Chan, Deanna Morrow, David Lurie
Zitieren
APA
Chan, Q. Y. P., Morrow, D., & Lurie, D. (2024). Canine primary liver tumors treated with stereotactic body radiation therapy: A case series. Veterinary Radiology & Ultrasound. https://doi.org/10.1111/vru.13336
Vancouver
Chan QYP, Morrow D, Lurie D. Canine primary liver tumors treated with stereotactic body radiation therapy: A case series. Veterinary Radiology & Ultrasound. 2024. doi:10.1111/vru.13336
BibTeX
@article{Chan2024,
author = {Chan, Qiao Ying Pauline and Morrow, Deanna and Lurie, David},
title = {Canine primary liver tumors treated with stereotactic body radiation therapy: A case series},
journal = {Veterinary Radiology & Ultrasound},
year = {2024},
doi = {10.1111/vru.13336}
}
EUVIMED